Topical vs Oral Finasteride: What the Spray Trial Shows and Why US Topicals Are Compounded

A finasteride spray beat placebo in a 24-week European trial and looked similar to tablets. In the US, no topical version is FDA-approved, and the FDA has warned about compounded ones.

This guide

Finasteride
Question
Is topical finasteride as good as the pill, and is it safer?
Sources
4 cited
Quick answers
2 questions
Clinician review
None; sources cited inline

Researched and written by Kymata Health Editorial; sources cited inline. Drawn from the studies and documents cited below. Educational only, not medical advice.

Key takeaways

4 points
  • Oral finasteride 1 mg is the FDA-approved form, for men only1.
  • In a 24-week trial of 458 men, run largely by its developer, finasteride spray added 20.2 hairs in the target area vs 6.7 with placebo, numerically similar to tablets2.
  • Side effects with the spray did not differ meaningfully from placebo in that trial2.
  • No topical finasteride is FDA-approved; the FDA counted 32 adverse-event reports for compounded topical versions from 2019 to 20243.

Oral finasteride

Finasteride 1 mg tablets are indicated for male pattern hair loss in men only1. In two 1-year trials of 1,553 men, the tablets improved hair by every measure used while placebo users kept losing hair4.

The finasteride spray trial

A phase III, double-blind trial at 45 European sites randomized 458 men to finasteride spray, finasteride tablets or placebo for 24 weeks. Target-area hair count rose by 20.2 hairs with the spray vs 6.7 with placebo, and the spray and tablets were numerically similar2. Adverse events with the spray did not differ meaningfully from placebo2. Seven of its ten authors worked for Almirall, the spray's developer2.

The trial lasted 24 weeks, so it cannot show long-term results or rare and persistent side effects2.

Topical finasteride in the US

There is no FDA-approved topical finasteride in the US; the sprays and finasteride-minoxidil mixes sold online are compounded. The FDA says compounded drugs are not evaluated for safety, effectiveness or quality, that finasteride applied to the skin is absorbed into the bloodstream, and that topical products raise the risk of transfer to others, including women3. It received 32 adverse-event reports from 2019 to 2024, including erectile dysfunction, anxiety, depression and suicidal ideation3.

Because finasteride can harm a male fetus, women who are or may be pregnant must avoid exposure1. For the full picture see the finasteride hub.

Quick answers

Questions

2 answers

Is topical finasteride FDA-approved?

No. Topical finasteride sold in the US is compounded, and the FDA has warned about it3.

Does the spray work as well as the pill?

In one 24-week trial run largely by the spray's developer, hair-count gains were numerically similar2.

References

Every study and document cited in this guide, numbered as in the text.

Sources

4 sources
  1. 1PROPECIA (finasteride) tablets, film coated: prescribing information. DailyMed, U.S. National Library of Medicine, 2024.
  2. 2Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol, 2022. PMID 34634163
  3. 3FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products. U.S. Food and Drug Administration, 2025.
  4. 4Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol, 1998. PMID 9777765

Dietary supplements are not intended to diagnose, treat, cure or prevent any disease, and these statements have not been evaluated by the FDA. Prescription options need a licensed clinician. Talk to your clinician or pharmacist before starting anything new, especially if you take prescription medicines, are pregnant or breastfeeding.

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.